Source: Annual Congress 2007 - Congenital and acquired lung disorders: diagnostic and therapeutic indications in infants and children
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Khalilzadeh, M. R. Bloorsaz, N. Baghaie, S. Hakimi (Tehran, Islamic Republic Of Iran). Clinical and paraclinical manifestations of pulmonary alveolar proteinosis in children. Eur Respir J 2007; 30: Suppl. 51, 2381

Member's Comments

No comment yet.

Related content which might interest you: Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan Source: Eur Respir J 2011; 37: 465 Year: 2011 LATE-BREAKING ABSTRACT: Clinical features common to five cases with secondary pulmonary alveolar proteinosis complicated with Behcet disease Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside Year: 2012 Clinical and radiological variants of fibrosis pulmonary sarcoidosis Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020 Pulmonary alveolar proteinosis and idiopathic pulmonary hemosiderosis Source: International Congress 2019 – CCC Airway diseases Year: 2019 Clinical course and morphological signs of idiopathic pulmonary fibrosis and interstitial pneumonias Source: Eur Respir J 2004; 24: Suppl. 48, 536s Year: 2004 Clinical assessment and management of pulmonary alveolar proteinosis: the importance of a reference centre Source: Annual Congress 2009 - Pulmonary alveolar proteinosis: clearing the Milky Way Year: 2009 Occupational and environmental impact on the clinical course of autoimmune pulmonary alveolar proteinosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012 Our cases with pulmonary alveolar proteinosis Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Intercurrent intractable factors in autoimmune pulmonary alveolar proteinosis Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009 Possible ocular involvement in pulmonary alveolar proteinosis Source: Eur Respir J 2006; 28: 456 Year: 2006 Diagnostic value of radiographic findings with literature review in Chinese pulmonary alveolar proteinosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 744s Year: 2006 Clinical characteristics of pulmonary alveolar microlithiasis in Japan Source: Eur Respir J 2004; 24: Suppl. 48, 670s Year: 2004 Pulmonary alveolar proteinosis and long-term outcome after bronchopulmonary lavage Source: International Congress 2017 – Paediatric bronchology Year: 2017 Alveolar proteinosis: epidemiology, possibilities of diagnosis Source: Eur Respir J 2004; 24: Suppl. 48, 671s Year: 2004 Pulmonary alveolar proteinosis: from classification to therapy Source: Breathe, 16 (2) 200018; 10.1183/20734735.0018-2020 Year: 2020 Radiological features of NTM pulmonary disease in patients with bronchiectasis Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020 Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010 Pulmonary alveolar proteinosis (PAP) - clinical features and response to treatment by bronchofiberoscopic lobar lavage Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005